Korean J Gastroenterol.  2017 Jan;69(1):59-63. 10.4166/kjg.2017.69.1.59.

Preparation, Evaluation, and Recovery before and after Conscious Sedative Endoscopy

• Park HJ
• Son BK
• Koo HS
• Kim BW

• KMID: 2383432
• DOI: http://doi.org/10.4166/kjg.2017.69.1.59

Abstract

No abstract available.

Keyword

Endoscopy; Conscious sedation

MeSH Terms

Conscious Sedation
Endoscopy*

Reference

References

1. Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology. 2007; 133:675–701.

2. McQuaid KR, Laine L. A systematic review and metaanalysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointest Endosc. 2008; 67:910–923.

3. Schroeder C, Kaoutzanis C, Tocco-Bradley R, et al. Patients prefer propofol to midazolam plus fentanyl for sedation for colonoscopy: results of a single-center randomized equivalence trial. Dis Colon Rectum. 2016; 59:62–69.

4. Lee CK, Dong SH, Kim ES, et al. Room for quality improvement in endoscopist-directed sedation: results from the first nationwide survey in Korea. Gut Liver. 2016; 10:83–94.

5. Ferreira AO, Torres J, Barjas E, et al. Non-anesthesiologist administration of propofol sedation for colonoscopy is safe in low risk patients: results of a noninferiority randomized controlled trial. Endoscopy. 2016; 48:747–753.

6. American Association for Study of Liver Diseases; American College of Gastroenterology. American Gastroenterological Association Institute. Multisociety sedation curriculum for gastrointestinal endoscopy. Gastrointest Endosc. 2012; 76:e1–e25.

7. Dumonceau JM, Riphaus A, Beilenhoff U, et al. European curriculum for sedation training in gastrointestinal endoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA). Endoscopy. 2013; 45:496–504.

8. Dumonceau JM, Riphaus A, Schreiber F, et al. Non-anesthesiolo-gist administration of propofol for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline–Updated June 2015. Endoscopy. 2015; 47:1175–1189.

9. Triantafillidis JK, Merikas E, Nikolakis D, Papalois AE. Sedation in gastrointestinal endoscopy: current issues. World J Gastroenterol. 2013; 19:463–481.

10. Agostoni M, Fanti L, Gemma M, Pasculli N, Beretta L, Testoni PA. Adverse events during monitored anesthesia care for GI endoscopy: an 8-year experience. Gastrointest Endosc. 2011; 74:266–275.

11. Roh WS, Kim DK, Jeon YH, et al. Analysis of anesthesia-related medical disputes in the 2009–2014 period using the Korean Society of Anesthesiologists database. J Korean Med Sci. 2015; 30:207–213.

12. ASGE Standards of Practice Committee. Chandrasekhara V, Early DS, et al. Modifications in endoscopic practice for the elderly. Gastrointest Endosc. 2013; 78:1–7.

13. Enestvedt BK, Eisen GM, Holub J, Lieberman DA. Is the American Society of Anesthesiologists classification useful in risk stratification for endoscopic procedures? Gastrointest Endosc. 2013; 77:464–471.

14. Friedrich K, Stremmel W, Sieg A. Endoscopist-administered propofol sedation is safe – a prospective evaluation of 10,000 patients in an outpatient practice. J Gastrointestin Liver Dis. 2012; 21:259–263.

15. Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology. 2007; 133:675–701.

16. Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA. 1961; 178:261–266.

17. Fitz-Henry J. The ASA classification and perioperative risk. Ann R Coll Surg Engl. 2011; 93:185–187.

18. Haynes SR, Lawler PG. An assessment of the consistency of ASA physical status classification allocation. Anaesthesia. 1995; 50:195–199.

19. Wani S, Azar R, Hovis CE, et al. Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures. Gastrointest Endosc. 2011; 74:1238–1247.

20. Berzin TM, Sanaka S, Barnett SR, et al. A prospective assessment of sedation-related adverse events and patient and endoscopist satisfaction in ERCP with anesthesiologist-administered sedation. Gastrointest Endosc. 2011; 73:710–717.

21. Vargo JJ. Procedural sedation and obesity: waters left uncharted. Gastrointest Endosc. 2009; 70:980–984.

22. Wani S, Azar R, Hovis CE, et al. Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures. Gastrointest Endosc. 2011; 74:1238–1247.

23. Friedman M, Tanyeri H, La Rosa M, et al. Clinical predictors of obstructive sleep apnea. Laryngoscope. 1999; 109:1901–1907.

24. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008; 108:812–821.

25. Jirapinyo P, Thompson CC. Sedation challenges: obesity and sleep apnea. Gastrointest Endosc Clin N Am. 2016; 26:527–537.

26. Rudner R, Jalowiecki P, Kawecki P, Gonciarz M, Mularczyk A, Petelenz M. Conscious analgesia/sedation with remifentanil and propofol versus total intravenous anesthesia with fentanyl, midazolam, and propofol for outpatient colonoscopy. Gastrointest Endosc. 2003; 57:657–663.

27. Chung F, Chan VW, Ong D. A post-anesthetic discharge scoring system for home readiness after ambulatory surgery. J Clin Anesth. 1995; 7:500–506.